Skip to main content

Viatris

Viatris Inc is a global healthcare company formed through the combination of Mylan and Upjohn, a former division of Pfizer. The company's business operations center on the development, manufacturing, and distribution of prescription branded medicines, generic drugs, and complex biosimilars. Revenue is primarily driven by sales of established pharmaceuticals targeting cardiovascular health, central nervous system disorders, infectious diseases, and immunology. Its principal end markets encompass retail pharmacies, hospital networks, government health agencies, and patients across more than 165 countries. The company's portfolio features recognized global brands such as Lipitor, Viagra, Norvasc, Lyrica, and EpiPen. Viatris ranks as one of the largest pharmaceutical suppliers of generic and legacy branded therapeutics in the world. The company is headquartered in Canonsburg, Pennsylvania, United States, and its stock is listed on Nasdaq.

35 of the funds FundTelligence covers report a position in Viatris.

Legal name
Viatris Inc
Sector
Health Care
Country
United States
Funds holding it
35

Funds holding Viatris

Showing the 8 largest of 35 funds holding it.

Loading...